Innovation drive in the field of digital urine volume measurement through cooperation between pfm medical ag and Observe Medical
Since January 2015 pfm medical owns the exclusive distribution rights for “SIPPI®”, the first and unique fully automatic, digital urine volume measurement system worldwide made by the Swedish manufacturer Observe Medical.
Urine production is an important component in maintaining a balance of fluids in patients, which makes it one of the vital parameters that need constant monitoring. For this reason SIPPI® is used mainly in intensive care units for various disciplines.
Simple operation, automatic emptying and the immediate availability of data simplify application for the medical staff. Without physical contact during the reading and fitted with a needle-free sampling point, SIPPI® makes an additional contribution to hygiene and the protection of staff.
The avoidance of hygiene problems from bacterial biofilm is a constant challenge in hospital work. SIPPI® supports the prevention of biofilm with a twofold protection integrated into the system: the Sippcoat™ zone in the replaceable measuring chamber has an antimicrobial agent reducing the growth of biofilm. The Sippsense™ biofilm indicator monitors the level of bacterial culture and calls in good time for the temporary barrier against biofilm to be renewed.
When the system is started, the automatic calibration function ensures the precision of the continuous measurement process with indications at one-minute intervals. Exact volume measurements with sensor technology at precise intervals of sixty minutes and storage of the measuring values history make a major contribution to quality assurance in the hospital.
pfm medical ag
pfm medical ag is a globally operating industrial company for medical technology with its head office in Cologne. As an independent manufacturer, technology partner, service provider and sales specialist, pfm medical is totally committed to the safety of users and patients. This family-run enterprise supplies a range of products including surgery supplies, surgical implants, histotechnology, cardiovascular technologies and also therapy management. Over 400 employees at thirteen subsidiaries and branches all over the world generate a turnover of around € 88.5 million.